Vericel (VCEL) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Vericel (VCEL) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Vericel | 2.33 Bn | 2.18 Bn | 49.27 Mn | -1.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.09% |
| Dec 31, 2025 | 5.08% |
| Sep 30, 2025 | 23.71% |
| Jun 30, 2025 | 50.30% |
| Mar 31, 2025 | 92.04% |
| Dec 31, 2024 | 147.77% |
| Sep 30, 2024 | 192.60% |
| Jun 30, 2024 | 212.23% |
| Mar 31, 2024 | 209.90% |
| Dec 31, 2023 | 162.90% |
| Sep 30, 2023 | 89.82% |
| Jun 30, 2023 | 47.04% |
| Mar 31, 2023 | 25.92% |
| Dec 31, 2022 | 19.00% |
| Sep 30, 2022 | 34.68% |
| Jun 30, 2022 | 50.32% |
| Mar 31, 2022 | 59.22% |
| Dec 31, 2021 | 74.35% |
| Sep 30, 2021 | 66.11% |
| Jun 30, 2021 | 50.43% |